A swallowable spy pill could unlock Sjögren's secrets

NCT ID NCT07732582

Not yet recruiting Knowledge-focused Sponsor: Tufts University Source: ClinicalTrials.gov ↗

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This study uses a novel ingestible mini-pill to collect bacteria samples from different parts of the gut in people with Sjögren's disease and healthy volunteers. By comparing these samples with mouth and stool bacteria, researchers hope to understand how the microbiome relates to Sjögren's. The goal is to identify unique bacterial patterns that could lead to better diagnosis or treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ingestible mini-pill sampling device
What this could lead to: If successful, this could reveal how gut and mouth bacteria differ in Sjögren's disease, pointing toward new ways to diagnose or manage the condition.
What could go wrong: This is an early exploratory study focused on observation, not treatment. It may not find clear differences, and the mini-pill technology is still being tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SJOGREN'S SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Sjogren syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SJOGREN'S SYNDROME

Contacts and locations

Locations

Tufts University School of Dental Medicine

Boston, Massachusetts, 02111, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.